DEN120022 is an FDA 510(k) submission (not cleared) for the X-RAY ATTENUATING CREAM. Classified as Cream For X-ray Attenuation (product code PDK), Class II - Special Controls.
Submitted by Bloxr Corporation (Salt Lake City, US). The FDA issued a Not Cleared (DENG) decision on May 9, 2013 after a review of 183 days.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.6510 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Radiology review framework.